Latest News

Adolescents: Medical use for prescription stimulants increase, nonmedical use decreases | Image Credit: © DedMityay - © DedMityay- stock.adobe.com.
Adolescents: Medical use for prescription stimulants increase, nonmedical use decreases

August 6th 2025

Findings may help guide clinicians and policymakers in balancing the risks and benefits of stimulant prescribing in adolescent populations, according to the study authors.

FDA revises labeling on extended-release stimulants for ADHD to include weight loss risk | Image Credit: Contemporary Pediatrics
FDA revises labeling on extended-release stimulants for ADHD to include weight loss risk

July 1st 2025

Pediatric FDA, clinical trial, and interview recap from Q1 2025 | Image Credit: © Araki Illustrations - © Araki Illustrations  - stock.adobe.com.
Q1 2025: A recap of the top headlines and interviews

April 3rd 2025

Cingulate reports phase 3 safety data for CTx-1301 to treat ADHD in children, adolescentsLatest revision | Image Credit: © Stepan Popov - © Stepan Popov - stock.adobe.com.
Cingulate reports phase 3 safety data for CTx-1301 to treat ADHD in children, adolescents

March 4th 2025

ADHD with ASD and without it: Should they be treated differently? | Image credit: Contemporary Pediatrics
ADHD with ASD and without it: Should they be treated differently?

January 29th 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.